Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7201 USD | +1.28% | +1.54% | -19.09% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stephan Jackman
CEO | Chief Executive Officer | 48 | 18-11-19 |
David Katzoff
DFI | Director of Finance/CFO | 63 | 19-10-31 |
William Horne
CHM | Chairman | 55 | 16-05-31 |
Henry Nisser
BRD | Director/Board Member | 56 | 19-04-30 |
James Turner
LAW | General Counsel | 49 | 21-03-31 |
Kenneth Cragun
PRN | Corporate Officer/Principal | 63 | 18-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Gustafson
BRD | Director/Board Member | 64 | 21-05-31 |
Todd Ault
FOU | Founder | 54 | 16-02-24 |
William Horne
CHM | Chairman | 55 | 16-05-31 |
Jeffrey Oram
BRD | Director/Board Member | 56 | 21-05-31 |
Henry Nisser
BRD | Director/Board Member | 56 | 19-04-30 |
Lynne McGrath
BRD | Director/Board Member | 69 | 21-05-31 |
Stephan Jackman
CEO | Chief Executive Officer | 48 | 18-11-19 |
Andrew Woo
BRD | Director/Board Member | 61 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,866,846 | 4,831,824 ( 70.36 %) | 0 | 70.36 % |
Company contact information
Alzamend Neuro, Inc.
3480 Peachtree Road NE Suite 103
30326, Atlanta
+844 722 6333
http://www.alzamend.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.09% | 4.88M | |
+0.22% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.81% | 24.63B | |
-22.87% | 18.2B | |
+27.84% | 12.01B | |
-2.39% | 11.76B | |
+15.34% | 10.4B | |
-5.35% | 9.94B |
- Stock Market
- Equities
- ALZN Stock
- Company Alzamend Neuro, Inc.